India Has 20% Of The World’s Diseases, But Just 4% Of Clinical Trials | Roche’s Mission

India accounts for 17% of the world’s population and a staggering 20% of the global disease burden, yet only 4% of global clinical trials are conducted here. Why the gap? Mistrust, limited infrastructure, and low participation rates are holding India back. Pharma giant Roche is stepping up to change that, partnering with trusted public hospitals like PGIMS Rohtak to build a robust clinical trial ecosystem. From capacity-building in government institutes to running India’s first dengue vaccine trial with 10,000 participants, Roche is ensuring Indian patients are represented in global data. Dr. Sivabalan Sivanesan, CMD of Roche, and Dr. Ruma Bhagat, Head of Population Science, explain how they’re tackling challenges in oncology, ophthalmology, neurology, immunology, and cardiovascular disorders. Meanwhile, Dr. Savita Verma shares insights from the ground on creating authentic, safe, and impactful trials. Can India close the gap and become a clinical trial powerhouse? Dive into this explainer to uncover the challenges, solutions, and Roche’s bold vision for India’s healthcare future! Like, subscribe, and hit the bell for more deep dives into global health trends!